Biotech Phanes Therapeutics Announces Positive Phase 2 Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026 January 11, 2026
Biotech Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA) January 10, 2026
Biotech Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology January 9, 2026
Biotech Complement Therapeutics Announces FDA Fast Track Designation for CTx001 for the Treatment of Geographic Atrophy Secondary to AMD January 8, 2026
Biotech AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board January 7, 2026
Biotech CIMG Inc. Announces Entry into Computing Power Industry; Initial Contracts with Aggregate Value of Approximately $124 Million January 6, 2026
Biotech GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy January 5, 2026
Biotech MarathonLS and Pacer Announce Strategic Separation into Two Independent Organizations January 3, 2026
Biotech Last day of trading in shares with pre-emptive rights in connection with rights issue January 2, 2026
Search
Biotech
January 11, 2026
January 10, 2026
January 9, 2026
January 8, 2026
January 7, 2026
January 6, 2026
January 5, 2026
January 4, 2026
January 3, 2026
January 2, 2026
